Managing common complex symptomatic epilepsies: tumors and trauma: american epilepsy society - 2012 annual course summary

Affiliations

¹ Epilepsy Program, Western University, London, Ontario, Canada.
² Departments of Neurology, Mayo Clinic in Arizona, Phoenix, AZ.
³ Mayo Clinic, Rochester, MN.
⁴ Medical Centre the Hague, Netherlands.
⁵ Cleveland Clinic Neuroscience Institute, OH.
⁶ Barrow Neurological Institute, Phoenix, AZ.
⁷ Northeast Regional Epilepsy Group, Atlantic Neurosciences Institute, Summit, NJ.
⁸ University of California, San Francisco, CA.
⁹ Duke University Medical Center, Durham, NC.
¹⁰ Mayo Clinic, Jacksonville, FL.
¹¹ Emory University, Atlanta, GA.
¹² Mayo Clinic, Phoenix, AZ.
¹³ Columbia University, New York, NY.
¹⁴ Beth Israel Deaconess Medical Center, Boston, MA.
¹⁵ University of Calgary, Calgary, Alberta, Canada.
¹⁶ University of California, Reed Neurological Research, Los Angeles, CA.
¹⁷ University of California, Los Angeles, CA.
¹⁸ United States Public Health Service, San Francisco, CA.
¹⁹ University of Pennsylvania.
²⁰ Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong.
²¹ Johns Hopkins Hospital, Baltimore, MD.
²² Thomas Jefferson University, Philadelphia, PA.

Jorge G Burneo et al. Epilepsy Curr. 2013 Sep.

. 2013 Sep;13(5):232-5.

doi: 10.5698/1535-7597-13.5.232.

¹ Epilepsy Program, Western University, London, Ontario, Canada.
² Departments of Neurology, Mayo Clinic in Arizona, Phoenix, AZ.
³ Mayo Clinic, Rochester, MN.
⁴ Medical Centre the Hague, Netherlands.
⁵ Cleveland Clinic Neuroscience Institute, OH.
⁶ Barrow Neurological Institute, Phoenix, AZ.
⁷ Northeast Regional Epilepsy Group, Atlantic Neurosciences Institute, Summit, NJ.
⁸ University of California, San Francisco, CA.
⁹ Duke University Medical Center, Durham, NC.
¹⁰ Mayo Clinic, Jacksonville, FL.
¹¹ Emory University, Atlanta, GA.
¹² Mayo Clinic, Phoenix, AZ.
¹³ Columbia University, New York, NY.
¹⁴ Beth Israel Deaconess Medical Center, Boston, MA.
¹⁵ University of Calgary, Calgary, Alberta, Canada.
¹⁶ University of California, Reed Neurological Research, Los Angeles, CA.
¹⁷ University of California, Los Angeles, CA.
¹⁸ United States Public Health Service, San Francisco, CA.
¹⁹ University of Pennsylvania.
²⁰ Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong.
²¹ Johns Hopkins Hospital, Baltimore, MD.
²² Thomas Jefferson University, Philadelphia, PA.

No abstract available

Figures

1. Van Breemen MS, Wilms EB, Vecht CJ. Epilepsy in patients with brain tumours: Epidemiology, mechanisms, and management. Lancet Neurol. 2007;6:421–430. - PubMed
1. Smits A, Duffau H. Seizures and the natural history of World Health Organization Grade II gliomas: A review. Neurosurg. 2011;68:1326–1333. - PubMed
1. You G, Sha Z, Jiang T. The pathogenesis of tumor-related epilepsy and its implications for clinical treatment. Seizure. 2012;21:153–159. - PubMed
1. Weller M, Gorlia T, Cairncross JG, van den Bent MJ, Mason W, Belanger K, Brandes AA, Bogdahn U, Macdonald DR, Forsyth P, Rossetti AO, Lacombe D, Mirimanoff RO, Vecht CJ, Stupp R. Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma. Neurology. 2011;77:1156–1164. - PMC - PubMed
1. Jakola AS, Myrmel KS, Kloster R, Torp SH, Lindal S, Unsgård G, Solheim O. Comparison of a strategy favoring early surgical resection vs a strategy favoring watchful waiting in low-grade gliomas. JAMA. 2012;308:1881–1888. - PubMed